Experienced in Spasmodic Dysphonia

Seung C. Lee

Goyang, KR 
Experienced in Spasmodic Dysphonia
Goyang, KR 
OverviewLocationsClinical Research

Overview

Seung Lee practices in Goyang, Republic of Korea. Mr. Lee is rated as an Experienced expert by MediFind in the treatment of Spasmodic Dysphonia. His top areas of expertise are Cardiac Arrest, Papillary Thyroid Cancer, Traumatic Brain Injury, Appendicitis, and Thyroidectomy.

His clinical research consists of co-authoring 64 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Spasmodic Dysphonia.

Gender
Male

Locations

Goyang, Republic of Korea
Other Locations
Gwangju, Republic of Korea
Ilsan, Republic of Korea
Department Of Otorhinolaryngology Head And Neck Surgery, Cheonan, Republic of Korea
Daejeon, Republic of Korea
Seoul, Republic of Korea
Pohang, Republic of Korea
Department Of Otorhinolaryngology Head And Neck Surgery, Puch'on, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-1
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-1
Enrollment Status: Completed
Publish Date: September 25, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

64 Total Publications

The epidemiology and outcomes of severe road traffic injury by road user type in Korea: A nationwide retrospective observational study.
The epidemiology and outcomes of severe road traffic injury by road user type in Korea: A nationwide retrospective observational study.
Journal: Injury
Published: February 07, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lee's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile